Gold tier: mechanically validated evidence, with its primary source.
26 evidence items · page 1 / 2
33.9 %Guideline-concordant treatment was documented for colorectal cancer in 33.9% of the curable cancer subcohort (9.5% of 3246 patients population based).
Namibiecolorectal cancerpublished 2025Journal of the National Cancer Instituteeurope_pmcdocument of 9 observations
5 %Of the 23 health districts, 12 had receptive PAPfPR2-10 risks of 5% to 18%.
Namibiepaludismepublished 2013BMC infectious diseaseseurope_pmcdocument of 4 observations
59 %The overall relative survival for breast cancer was 59.0% at Year 5.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
59.8 %Guideline-concordant treatment was documented for aggressive non-Hodgkin lymphoma in 59.8% of the curable cancer subcohort (9.1% of 3246 patients population based).
Namibieaggressive non-Hodgkin lymphomapublished 2025Journal of the National Cancer Instituteeurope_pmcdocument of 9 observations
6.1 %Diabetes prevalence was 6.1% in Namibia in 2013.
Namibiediabète (non précisé)observed 2013HAL · Unilimdocument of 120 observations
33 %In Namibia, 33% of cholera cases were among children under 15 years old.
Namibiecholéraobserved Jun 2025 – 31 July 2025Africa CDCdocument of 176 observations
65.8 %The overall relative survival for breast cancer was 65.8% at Year 3.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
1 deathsNamibia reported 1 cholera death, with the outbreak starting in June 2025.
Namibiecholéraobserved Jun 2025Africa CDCdocument of 176 observations
84.5 %The 3-year relative survival for breast cancer was 84.5% in Namibia.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
40.3 %Patients diagnosed at advanced stages (III and IV) had a 3-year relative survival of 40.3%.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
86.1 %The overall relative survival for breast cancer was 86.1% at Year 1.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
54.5 %Guideline-concordant treatment was documented for breast cancer in 54.5% of the curable cancer subcohort (19.0% of 3246 patients population based).
Namibiecancer du seinpublished 2025Journal of the National Cancer Instituteeurope_pmcdocument of 9 observations
39 %Guideline-concordant treatment was documented for prostate cancer in 39.0% of the curable cancer subcohort (6.1% of 3246 patients population based).
Namibiecancer de la prostatepublished 2025Journal of the National Cancer Instituteeurope_pmcdocument of 9 observations
64.9 %Among patients with known stage, 64.9% were diagnosed in late stages.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
41.3 %In the subcohort with curable cancer, guideline-concordant treatment was documented in 374 (41.3%, corresponding to 11.7% of 3246 patients included in the population-based cohort).
Namibiecurable cancerpublished 2025Journal of the National Cancer Instituteeurope_pmcdocument of 9 observations
27.8 %Guideline-concordant treatment was documented for cervical cancer in 27.8% of the curable cancer subcohort (11.6% of 3246 patients population based).
Namibiecancer du col de l'utéruspublished 2025Journal of the National Cancer Instituteeurope_pmcdocument of 9 observations
78 %Patients diagnosed at early stages had a 3-year relative survival of 78%.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
13 per_1000The mean annual malaria incidence in Namibia was 13 cases per 1000 population, based on Bayesian model predictions.
Namibiepaludismepublished 2013Spatial and spatio-temporal epidemiologyeurope_pmcdocument of 4 observations
17 casesNamibia reported 17 cholera cases and 1 death, with the outbreak starting in June 2025.
Namibiecholéraobserved Jun 2025Africa CDCdocument of 176 observations
144,744 casesIn Namibia in 2009, there were 144,744 malaria cases recorded.
Namibiepaludismeobserved 2009published 2013Spatial and spatio-temporal epidemiologyeurope_pmcdocument of 4 observations
90 %Over 90% of the 1.4 million people across the nine regions of northern Namibia appear to have transitioned to a lower endemic class by 2009.
Namibiepaludismeobserved 2009published 2013BMC infectious diseaseseurope_pmcdocument of 4 observations
134,851 casesIn Namibia in 2009, 134,851 malaria cases were suspected.
Namibiepaludismeobserved 2009published 2013Spatial and spatio-temporal epidemiologyeurope_pmcdocument of 4 observations
17 casesIn Namibia, there were 17 cholera cases and 1 death from June 2025 to July 2025.
Namibiecholéraobserved Jun 2025 – 31 July 2025Africa CDCdocument of 176 observations
9,893 casesIn Namibia in 2009, 9,893 malaria cases were parasitologically confirmed.
Namibiepaludismeobserved 2009published 2013Spatial and spatio-temporal epidemiologyeurope_pmcdocument of 4 observations
21.6 %The 3-year relative survival for breast cancer was 21.6% in Bulawayo.
Namibiecancer du seinobserved 2008-2015published 2020International journal of cancereurope_pmcdocument of 9 observations
Every row leads to its source document. The figure shown counts the VALIDATED observations it carries, never the extracted ones: the two differ on most documents. The exact source excerpt is not published, due to copyright constraints.